Characteristics, Complexation and Analytical Methods of Darunavir

References (19)

1. 1 Validation of high-performance liquid chromatography methods for pharmaceutical analysis [DOI]
2. 2 Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir [DOI]
3. 3 Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs [DOI]
4. 4 Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds [DOI]
5. 5 Drug delivery systems in HIV pharmacotherapy: What has been done and the challenges standing ahead [DOI]
6. 6 A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine [DOI]
7. 7 Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry [DOI]
8. 8 HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions [DOI]
9. 9 Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non‐nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry [DOI]
10. 10 A liquid chromatography–tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV [DOI]
11. 11 A novel LC–ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma [DOI]
12. 12 Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection [DOI]
13. 13 Solid state characterization of the anti-HIV drug TMC114: Interconversion of amorphous TMC114, TMC114 ethanolate and hydrate [DOI]
14. 14 The Validation of Plasma Darunavir Concentrations Determined by the HPLC Method for Protease Inhibitors [DOI]
15. 15 Development and validation of infrared spectroscopy method for the determination of darunavir in tabets [DOI]
16. 16 Application of a validated ultra performance liquid chromatography–tandem mass spectrometry method for the quantification of darunavir in human plasma for a bioequivalence study in Indian subjects [DOI]
17. 17 Improved bioavailability of darunavir by use of κ-carrageenan versus microcrystalline cellulose as pelletisation aid [DOI]
18. 18 The Estimation of Darunavir in Tablet dosage form by RP-HPLC.
19. 19 Características químicas, mecanismo de acción y actividad antiviral de darunavir [DOI]

Cited by 12

Showing 5 of 12 known citations — external sources report more than can currently be individually listed.

Related research

• Identifying and Mitigating Human Errors in Laboratory Quality Control Systems — shares topic coverage
• Microbial Count of Non-sterile Pharmaceutical Products Sold in Pakistan — shares topic coverage
• Contribution of InvA Gene PCR to Recovery of Salmonella spp. Strains — shares topic coverage
• Quality Control of Certain Herbal Products and Their Individual Components Used for Digestive Tract Disorders and Their Proposed Mechanism — shares topic coverage
• Standardization of Amukkirai Chooranam, a Traditional Herbal Preparation in Siddha System of Medicine — shares topic coverage